Evaluation des maladies aiges chez le patient VIH - PowerPoint PPT Presentation

1 / 63
About This Presentation
Title:

Evaluation des maladies aiges chez le patient VIH

Description:

Evaluation des maladies aig es chez le patient VIH. Dr ... 48 hours later, the patient was afebrile. Progressively, diarrhea and abdominal pain resolved ... – PowerPoint PPT presentation

Number of Views:100
Avg rating:3.0/5.0
Slides: 64
Provided by: sommer5
Category:

less

Transcript and Presenter's Notes

Title: Evaluation des maladies aiges chez le patient VIH


1
Evaluation des maladies aigües chez le patient VIH
  • Dr Stéphane DE WIT
  • CHU Saint-Pierre
  • Bruxelles

2
Histoire naturelle de linfection à VIH

3
Impact des trithérapies
4
  • HAART
  • ? ? réplication virale
  • ? ? charge virale
  • ? risque immunodéficience
    Immunorestauration
  • ? ? risques complications cliniques de
    limmunodéficience
  • ? ? morbidité
  • ? ? mortalité
  • et rétablissement dun pronostic à long terme

5
Impact clinique des HAART
  • Diminution drastique de la mortalité
  • Diminution de lincidence de la plupart des OIs
    et cancers
  • Reduction du risque de récidive des OIs
  • Syndromes dimmunoreconstitution
  • Effets secondaires
  • Lypodystrophie
  • Intolerance au glucose
  • ? Risque cardiovasculaire accru
  • Effets rétinoïdes

6
Antirétroviraux en 2004
Inhibiteurs de la reverse Inhibiteurs
transcriptase de protéase
analogues nucleosidiques - zidovudine (AZT,
ZDV) - saquinavir (SQV) - didanosine (ddl) -
ritonavir (RTV) - zalcitabine (ddC) -
indinavir (IDV) - stavudine (d4T) -
nelfinavir (NFV) - lamivudine (3TC) -
amprenavir (APV) - abacavir (ABC) -
lopinavir/r (LPV/r) analogue nucleotidique -
atazanavir (ATV) - tenofovir (TFV) -
tipranavir (TPV) non-nucleosidiques inh
ibiteur de fusion - nevirapine
(NVP) -enfuvirtide (T20) - efavirenz (EFV)
7
Quel patient pour quelle pathologie?
  • Patient non traité (ou en échec thérapeutique ?),
  • non prophylacté (voire non diagnostiqué)
  • - toute infection, opportuniste ou non
  • - néoplasie
  • - non lié à lHIV
  • Patient traité (et prophylacté)
  • - infections non opportunistes (ou
    opportunistes) cf CD4
  • syndrome dimmunorestauration
  • - effets secondaires
  • - néoplasies
  • - non liés à HIV, ni au traitement

8
Histoire naturelle de linfection à VIH

9
Infections/Cancers et lymphocytose CD4
  • Pyogènes -----------------------------------------
    --------?
  • Tuberculose --------------------------------------
    --------?
  • Herpes (simplexzoster) -------------------------
    -----?
  • Pneumocystose ------------------------?
  • Mycose buccale oesophagienne ------?
  • Toxoplasmose -----------?
  • CMV -----------------------?
  • Cryptococcose -----------?
  • Mycobactériose
  • LEMP
  • Kaposi ------------------------------------?
  • Lymphome ---------------?

CD4
200
100
Salmonella Pneumocoque
10
Clinical case (1)
11
  • 45-years-old woman hospitalized for cough, chest
    pain increased by breathing and weight loss of 10
    kg
  • ltCongo, in Belgium since 18 years
  • HIV-infected since 17 years, CD4 87/µl and
    VLgt100000 despite a treatment with Lopi/rito ,
    tipranavir, ddI and T20.
  • Medical history
  • Chronic hepatitis B
  • Condyloma
  • Genital herpes
  • Pneumonia, Bronchiectasia

12
  • Physical examination Weight loss
  • Tenosynovitis of the left wrist
  • Biology
  • - Hb 9,4 g/dl, platelet 89000 (N 150-440), WBC
    2770 (55 neutrophils)
  • - CRP 22 mg/l
  • - ALT 90 (Nlt34 UI), AST 234 (Nlt47 UI), normal
    LDH
  • Chest X-ray micro-nodular infiltrate
  • Chest CT-scan bilateral micro-nodular infiltrate

13
(No Transcript)
14
(No Transcript)
15
What is the most likely diagnosis ?
  • 1. Pneumonia with atypical bacteria
  • 2. Tuberculosis
  • 3. Cryptococcal pneumonia
  • 4. PCP

16
What is the most likely diagnosis ?
  • 1. Pneumonia with atypical bacteria
  • 2. Tuberculosis
  • 3. Cryptococcal pneumonia
  • 4. PCP

17
What do you propose?
  • Blood and sputum cultures for bacteria
  • Sputum direct exams and cultures for mycobacteria
  • Intradermal reaction
  • Bronchoscopy with BAL
  • Bronchoscopy with BAL and lung biopsies

18
What do you propose?
  • Blood and sputum cultures for bacteria
  • Sputum direct exams and cultures for mycobacteria
  • Intradermal reaction
  • Bronchoscopy with BAL
  • Bronchoscopy with BAL and lung biopsies

19
  • A bronchoscopy with BAL was performed.
  • The Ziehl-Nielsen test was negative but the
    genprobe for mycobacterium tuberculosis was
    positive.

20
Which treatment do you start?
  • INH-Rifampicine-Pyrazinamide-Ethambutol
  • INH-Rifampicine-Pyrazinamide
  • INH-Rifabutine-Pyrazinamide-Ethambutol
  • INH-Rifabutine-Pyrazinamide

21
Which treatment do you start?
  • INH-Rifampicine-Pyrazinamide-Ethambutol
  • INH-Rifampicine-Pyrazinamide
  • INH-Rifabutine-Pyrazinamide-Ethambutol
  • INH-Rifabutine-Pyrazinamide

22
Syndrome respiratoire
  • Bronchite Pneumonie
  • Asthme
  • Embolie Radio LDH
  • etc, Gazo (CD4?)
  • Lobaire ? Pneumocoque, autre pyogène
  • Mal systématisé ( ganglions) LDH N, Gazo peu
    altérée
  • ? Tuberculose
  • Interstitielle, gazo a N, LDH ? ? ? PCP
  • Cotrimoxazole 3x4 ampoules
  • O2
  • corticoïdes (si pAO2lt60)

NB sinusites très fréquentes (Pneumocoque,)
? y songer si toux chronique, céphalées,
jettage postérieur.
23
  • Pneumococcal disease in hiv patients
  • x 50-100 risk for invasive pneumococcal disease
  • Ann Intern Med 2000132182
  • J Infect Dis 1996173857
  • Vaccination when CD4gt200/mm3 gives a better
    antibody response
  • If vaccination lt200 CD4 /mm3 Revaccinate when
    CD4gt200/mm3
  • Revaccinate every 5 years
  • Benefit ? in 1 placebo-controlled study
    unexplained deleterious effect in rural
    population in Uganda

24
Clinical case(2)
25
  • A Woman born in 1974 is admitted for confusion
    and decreased level of consciousness
  • She arrived in Belgium in 2000, from Liberia
    where she has been raped, she lives now with her
    husband
  • Medical History
  • Shingles in April 2001
  • HIV diagnosed in January 2002 in another
    hospital with CD4 49/µL and HIV-RNA 276.000 cp/ml
  • A triple therapy was prescribed repeatedly but
    never started
  • In January 2003, she is admitted in another
    hospital for cerebral toxoplasmosis but she
    demanded to be discharged before the end of
    hospitalisation.

26
  • Clinical examination
  • 39.9C
  • Blood pressure90/50 mm Hg
  • HB 100/min
  • Confused and abnormal behavior
  • Vertical eyes mobility is impaired
  • Peripheral right facial palsy
  • Partial right palsy of the arm
  • Urinary incontinence
  • Ataxy
  • Question 1 What exam do you propose ?
  • Blood and urinary bacterial cultures
  • Lumbar puncture
  • Brain scan or MR

27
  • Clinical examination
  • 39.9C
  • Blood pressure90/50 mm Hg
  • HB 100/min
  • Confused and abnormal behavior
  • Vertical eyes mobility is impaired
  • Peripheral right facial palsy
  • Partial right palsy of the arm
  • Urinary incontinence
  • Ataxy
  • Question 1 What exam do you propose ?
  • Blood and urinary bacterial cultures
  • Lumbar puncture
  • Brain scan or MR

28
A brain NMR shows a large mass (diameter 2.5
cm) with compression of the left capsula enhanced
after contrast and surrounded with edema
29

30
  • What is your diagnosis?
  • And what Treatment do you start?
  • Cerebral toxoplasmosis
  • Brain lymphoma
  • Cryptococcosis
  • Tuberculoma
  • Amphotericine B and 5 FC
  • Corticosteroids
  • Pyrimethamine/Sulfadiazine
  • AntiTBC quadritherapy

31
  • What is your diagnosis?
  • And what Treatment do you start?
  • Cerebral toxoplasmosis
  • Brain lymphoma
  • Cryptococcosis
  • Tuberculoma
  • Amphotericine B and 5 FC
  • Corticosteroids
  • Pyrimethamine/Sulfadiazine
  • AntiTBC quadritherapy

32
  • What is your diagnosis?
  • And what Treatment do you start?
  • Cerebral toxoplasmosis
  • Brain lymphoma
  • Cryptococcosis
  • Tuberculoma
  • Amphotericine B and 5 FC
  • Corticosteroids
  • Pyrimethamine/Sulfadiazine
  • AntiTBC quadritherapy

33
  • Treatment against toxoplasmosis is started
  • Sulfadiazine 1g x 4 /d
  • Daraprim 100 mg then 50 mg /d
  • ledervorin 10 mg /d (folinic acid)
  • CD4 65/µL (12)
  • Toxoplasmosis IgG

34
Troubles neurologiques
  • Interactions
  • Exclure cause médicamenteuse
  • Efavirenz
  • (avec contraste et clichés tardifs)
  • aN
  • N
  • Abcès toxo AVC
  • PL lymphome Pyogènes
  • LEMP Encéphalites virales
  • Pathologies rares (Herpes, HIV,)
  • Pyriméthamine (100mg puis 50mg/j)
    sulfadiazine 4g/j

CT scan ou RMN
35
Troubles neurologiques avec imagerie normale (1)
  • PL (5 à 6 cc)
  • numération formule
  • chimie protéines, glucose, HL
  • cellules néoplasiques
  • ED culture ordinaire
  • mycose (encre de chine)
  • mycobactéries
  • Ag cryptocoque
  • Culture virale
  • PCR CMV
  • Herpes
  • Toxo
  • EBV
  • Charge virale HIV

36
Troubles neurologiques avec imagerie normale (2)
  • antibactérien (ceftriaxone)
  • Traitement
  • amphotéricine B, 1mg/kg si encre de Chine ou
    Ag cryptocoque?

37
Clinical case(3)
38
  • 30-year-old woman from Uganda
  • In Belgium since 5 days
  • Hospitalized for fever, diarrhea and abdominal
    pain since one month
  • Medical history malaria
  • Physical examination
  • - 39,9C
  • - Hairy leucoplakia
  • - Sensitive hepatomegaly 4 cm

39
Exams
  • Positive HIV antibodies. CD4 cell count 10/µL.
  • Inflammatory syndrome CRP 169 mg/l, WBC 9950/µL
    (84 neutrophils)
  • Anemia with microcytosis
  • Chest and abdominal X-ray normal
  • Liver ultrasound normal
  • Stools negative for bacteria, parasite,
    microsporidia and cryptosporidium. Ziehl is also
    negative.
  • Blood cultures negative.

40
  • Abdominal CT scan
  • numerous mesenteric adenopathies, some with
    necrosis,ileitis,colitisand peritoneal liquid

41
What is the most likely diagnosis?
  • CMV colitis
  • Tuberculosis
  • Mycobacterium Avium Intracellulare
  • Kaposi sarcoma
  • Lymphoma
  • Crohn

42
What is the most likely diagnosis?
  • CMV colitis
  • Tuberculosis
  • Mycobacterium Avium Intracellulare
  • Kaposi sarcoma
  • Lymphoma
  • Crohn

43
What would you propose?
  • Intradermal reaction test
  • Blood cultures for mycobacteria
  • Colonoscopy
  • Laparoscopy with biopsies
  • Begin empirical treatment

44
What would you propose?
  • Intradermal reaction test
  • Blood cultures for mycobacteria
  • Colonoscopy
  • Laparoscopy with biopsies
  • Begin empirical treatment

45
  • A colonoscopy was performed which showed a
    diffuse colitis without ulcer but with intense
    inflammation of the mucous membrane.
  • Progression was more and more difficult and the
    caecum could not be reached.
  • Biospies were performed.

46
What would you propose now ?
  • Wait until you have the results of the biopsies
  • Begin a treatment against tuberculosis
  • Begin a treatment against tuberculosis and
    Mycobacterium avium intracellulare

47
What would you propose now ?
  • Wait until you have the results of the biopsies
  • Begin a treatment against tuberculosis
  • Begin a treatment against tuberculosis and
    mycobacterium avium intracellular

48
  • A treatment against tuberculosis was started with
    INH, rifampicin, pyrazinamide and ethambutol.
  • 48 hours later, the patient was afebrile.
    Progressively, diarrhea and abdominal pain
    resolved
  • The biopsies showed a positive Ziehl-Nielsen test
    and the culture a multisensitive Mycobacterium
    tuberculosis.

49
Syndrome abdominal
  • Prise en charge classique
  • Dysphagie mycose buccale ? Fluconazole 200mg/j
  • Si échec gastroscopie pour - pathologie non
    infectieuse - ulcération - groupe Herpes -
    idiopathique
  • Mise au point complémentaire à orienter en
    fonction des CD4 et du traitement (penser aux
    effets secondaires)
  • Vomissements
  • Diarrhée (Viracept)
  • Ictère (Crixivan , Reyataz)
  • Pancréatite (Videx, Zerit)
  • Colique néphrétique lt Crixivan

50
Diarrhée
  • Médicamenteuse.
  • Entéropathogènes Fréquence ? Salmonella, à
    tout niveau de T4
  • Parasites
  • incidence Giardia population générale
  • fréquence amibes ? chez homos
  • si immunité lt 100 T4/mm3 et Atteinte grêle -
    Cryptosporidium - Microsporidies -
    Cyclospora - Isospora
  • Atteinte colique - CMV

51
Ictère / Alt. tests hépatiques
  • Médicamenteuse
  • Hépatite B/C chronique en poussée
    aigue s ajoutant à toxicité médicamenteuse
  • Dans contexte T, et T4 lt 100
  • avec anémie MAI généralisé
  • avec leuco/pancytopénie ? diarrhée CMV
    généralisé
  • avec diarrhée/peu-pas T Cryptosporidium
  • Ne pas oublier (si cholostase pure) causes
    obstructives
  • - classiques - néoplasiques KS, lymphomes

52
Clinical case(4)
53
  • A 49-year-old HIV woman followed for HIV
    infection for 10 years stops her ARV therapy in
    June 2000.
  • In December 2001 her CD4 are 104 /mm3 VL is
    high and her doctor proposes to restart a therapy
    with Combivir, Abacavir, Ritonavir,Indinavir and
    Saquinavir.
  • 2 Weeks later she has suddenly fever (39C) and
    dry cough. She is admitted in another hospital
    (ICU) because of acute respiratory distress
    syndrome with bilateral lung infiltrates, acute
    renal failure, DIVC and shock.
  • Large spectrum antibiotics are given after
    multiple bacteriological samples are taken and
    ARV therapy is stopped.
  •  

54
  •  
  • What is your diagnosis?
  • Acute bacterial pneumonia with septic shock
  • Pneumocystis carinii pneumonia
  • Abacavir hypersensitivity
  • Tuberculosis
  • Myocardial infarct with cardiac failure

55
  •  
  • What is your diagnosis?
  • Acute bacterial pneumonia with septic shock
  • Pneumocystis carinii pneumonia
  • Abacavir hypersensitivity
  • Tuberculosis
  • Myocardial infarct with cardiac failure

56
  • All bacterial cultures are negative, direct
    exams for TB is neg BAL is also neg for PC.
  • The patient has a favorable evolution the shock
    and renal failure resolve within 48 hours and the
    lung infiltrates are cleared within 4 days.
  • She is transferred to the infectious disease
    department.
  •  
  • How do you treat the patient ?
  • Start anti TBC therapy
  • Finish treatment with antibiotics and resume her
    previous ARV therapy
  • Finish treatment with antibiotics and resume ARV
    therapy without ABC
  •  

57
  • All bacterial cultures are negative, direct
    exams for TB is neg BAL is also neg for PC.
  • The patient has a favorable evolution the shock
    and renal failure resolve within 48 hours and the
    lung infiltrates are cleared within 4 days.
  • She is transferred to the infectious disease
    department.
  •  
  • How do you treat the patient ?
  • Start anti TBC therapy
  • Finish treatment with antibiotics and resume her
    previous ARV therapy
  • Finish treatment with antibiotics and resume ARV
    therapy without ABC
  •  

58
After 10 days the patient restarted her previous
therapy. 2 hours after taking the pills she
developed a deep shock with a facial rash and dry
cough. She was transferred to the intensive care
where she received Levorenine for 2
days. Stavudine , Ritonavir, Indinavir and
Invirase were given thereafter with no further
complication and good therapeutic response.
59
Principaux effets secondaires des antirétroviraux
  • Inhibiteurs de la reverse transcriptase,
    analogues de nucléosides (Toxicité
    mitochondriale)
  • Zidovudine Rétrovir?, Combivir?, Trizivir?
  • Anémie, myopathie
  • Didanosine Videx?
  • Stavudine Zerit?
  • Abacavir Ziagen? Syndrome dhypersensibilité
  • Attention pas de rechallenge

Pancréatite Neuropathie
60
Principaux effets secondaires des antirétroviraux
  • Inhibiteurs non-nucléosidiques de la reverse
    transcriptase
  • Hépatotoxicité
  • Névirapine (Viramune?)
  • Rash
  • Efavirenz (Stocrin?)
  • Troubles neuro-psychiatriques

61
Principaux effets secondaires des antirétroviraux
  • Inhibiteurs de protéase
  • Effet de classe
  • Lipodystrophie avec ou sans anomalies
    lipidiques
  • Résistance à linsuline ? diabète
  • Troubles des phanères
  • Indinavir Crixivan?
  • Colique néphrétique
  • Insuffisance rénale
  • Nelfinavir Viracept?
  • Diarrhée
  • Amprénavir Agénérase?
  • Diarrhée, rash

62
Syndromes dimmunoreconstitution
  • MAC (adénite)
  • CMV (rétinite)
  • TBC
  • Cryptococcose
  • HBV HCV
  • Herpes Zoster
  • LEMP
  • Rendez-vous au prochain séminaire SIDA le
    mercredi 20 octobre à 20h au Forum du CHU Saint
    Pierre.

63
Bruxelles 12-13-14 mars 2005
  • 3èmes Journées VIH / SIDA
  • de la Francophonie
  • VIH2005.be
Write a Comment
User Comments (0)
About PowerShow.com